PROCEPT BioRobotics Corporation PRCT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.80% | -30.43% | -13.62% | -4.55% | 15.47% |
| Total Depreciation and Amortization | 29.98% | 20.65% | 20.36% | 22.09% | 20.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.12% | 27.56% | 32.00% | 40.08% | 65.05% |
| Change in Net Operating Assets | 42.71% | 45.73% | 33.04% | 83.44% | -57.80% |
| Cash from Operations | -7.94% | 10.66% | 16.42% | 50.63% | 22.45% |
| Capital Expenditure | 3.41% | -74.73% | -142.71% | -112.20% | 27.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.41% | -74.73% | -142.71% | -112.20% | 27.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.78% | -94.25% | -94.34% | -93.79% | 1,322.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -94.78% | -94.25% | -94.34% | -93.79% | 1,322.46% |
| Foreign Exchange rate Adjustments | -187.88% | -391.30% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.84% | -184.40% | -177.86% | -161.73% | 207.04% |